VYNE (STOCKS)
VYNE Therapeutics Inc. Common Stock
$0.610000
-0.038500 (-5.94%)
Prev close: $0.648500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Domzalski
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $21.01M
- Employees
- 13
- P/E (TTM)
- -1.17
- P/B (TTM)
- 0.88
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.08 | $-0.18 | +0.1036 | +56.43% |
|
Dec 2025 (Q4)
|
$-0.11 | $-0.18 | +0.0707 | +38.50% |
|
Sep 2025 (Q3)
|
$-0.17 | $-0.13 | -0.0374 | -28.21% |
|
Jun 2025 (Q2)
|
$-0.13 | $-0.23 | +0.0978 | +42.93% |